SGLT2i pharmacological treatment in type 2 diabetes mellitus control and its underlying obesity. (2024). Revista Portuguesa De Medicina Geral E Familiar, 40(2), 148-56. https://doi.org/10.32385/rpmgf.v40i2.13647